{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:42:37Z","timestamp":1770903757600,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003189","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ymgme.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T19:02:56Z","timestamp":1542913376000},"page":"139-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B"],"prefix":"10.1016","volume":"126","author":[{"given":"Michael J.","family":"Przybilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru-Flaviu","family":"T\u0103b\u0103ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-7294","authenticated-orcid":false,"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1703-2167","authenticated-orcid":false,"given":"Rohini","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Kell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Gerard","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.11.002_bb0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archpedi.1965.02090020340014","article-title":"Generalized gangliosidosis, another inborn error of ganglioside metabolism?","volume":"109","author":"O'Brien","year":"1965","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.159.3822.1471","article-title":"Cerebral GM1-gangliosidosis: chemical pathology of visceral organs","volume":"159","author":"Suzuki","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0015","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3775","article-title":"Beta-galactosidase deficiency (beta-galactosidosis): GM1 gangliosidosis and Morquio B disease","author":"Suzuki","year":"2001"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0020","first-page":"1091","article-title":"Human \u03b2-galactosidase gene mutations in morquio B","volume":"49","author":"Oshima","year":"1991","journal-title":"Dis. Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/humu.21031","article-title":"GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase","volume":"30","author":"Hofer","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ymgme.2010.03.019","article-title":"DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts","volume":"100","author":"Fantur","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2152\/jmi.53.103","article-title":"Elastogenesis in cultured dermal fibroblasts from patients with lysosomal \u03b2-galactosidase, protective protein\/cathepsin A and neuraminidase-1 deficiencies","volume":"53","author":"Tatano","year":"2006","journal-title":"J. Med. Investig."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0040","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1194\/jlr.M700308-JLR200","article-title":"Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients","volume":"48","author":"Santamaria","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s004390100570","article-title":"Mutation analyses in 17 patients with deficiency in acid \u03b2-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B","volume":"109","author":"Paschke","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1399-0004.1976.tb01603.x","article-title":"Sponyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid \u03b2-galactosidase deficiency","volume":"9","author":"O'Brien","year":"1976","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid \u03b2-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"\u03b2-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013468","article-title":"AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival","volume":"5","author":"Baek","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0070","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","article-title":"Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan","volume":"24","author":"Weismann","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.genet.40.110405.090451","article-title":"DNA double-strand break repair: all's well that ends well","volume":"40","author":"Wyman","year":"2006","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-genet-110410-132435","article-title":"Double-strand break end resection and repair pathway choice","volume":"45","author":"Symington","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13059-015-0653-x","article-title":"Cloning-free CRISPR\/Cas system facilitates functional cassette knock-in in mice","volume":"16","author":"Aida","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jgg.2016.02.004","article-title":"Delivery of Cas9 Protein into Mouse Zygotes through a Series of Electroporation Dramatically increases the Efficiency of Model creation","volume":"43","author":"Wang","year":"2016","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ydbio.2014.06.017","article-title":"Somatic mosaicism and allele complexity induced by CRISPR\/Cas9 RNA injections in mouse zygotes","volume":"393","author":"Yen","year":"2014","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:BIGI.0000034429.55418.71","article-title":"Inheritance of lysosomal acid \u03b2-galactosidase activity and gangliosides in crosses of DBA2J and knockout mice","volume":"42","author":"Hauser","year":"2004","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02535184","article-title":"A Convenient Method for the Preparation of Asialo-GM1","volume":"17","author":"Kasai","year":"1982","journal-title":"Lipids"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0125","first-page":"8.12.11","article-title":"Motor Coordination and Balance in Rodents","author":"Carter","year":"2001","journal-title":"Curr. Protocols Neurosci."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0130","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0135","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0145","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyarkumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0077579","article-title":"Memory Deficits Associated with Senescence: a Neurophysiological and Behavioral Study in the","volume":"93","author":"Barnes","year":"1979","journal-title":"Rat J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-4328(97)00214-3","article-title":"A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study","volume":"95","author":"Gerlai","year":"1998","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1074\/jbc.272.1.396","article-title":"Identification of Glu-268 as the catalytic nucleophile of human lysosomal","volume":"272","author":"McCarter","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124633","article-title":"CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool","volume":"10","author":"Stemmer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-2275(20)39594-8","article-title":"Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain","volume":"7","author":"Rosenberg","year":"1966","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1354\/vp.38-3-281","article-title":"GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings","volume":"38","author":"M\u00fcller","year":"2001","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0180","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/0300985810388522","article-title":"Pathology of GM2 gangliosidosis in Jacob sheep","volume":"48","author":"Porter","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0185","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parksonson's disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2018.11.002_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2017.11.013","article-title":"RTB lectin-mediated delivery of lysosomal alpha-l-iduronidase mitigates disease manifestations systemically including the central nervous system","volume":"123","author":"Ou","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0200","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/cge.13226","article-title":"SAAMP 2.0: an algorithm to predict genotype-phenotype correlation of lysosomal storage diseases","volume":"93","author":"Ou","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/bj2280443","article-title":"Absence of keratan sulphate from skeletal tissues of mouse and rat","volume":"228","author":"Venn","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0210","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1083\/jcb.141.5.1277","article-title":"Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican","volume":"141","author":"Chakravarti","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0215","doi-asserted-by":"crossref","first-page":"30306","DOI":"10.1074\/jbc.272.48.30306","article-title":"Characterization and expression of the mouse lumican gene","volume":"272","author":"Ying","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0220","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1074\/jbc.M111.293795","article-title":"Crystal structure of human beta-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases","volume":"287","author":"Ohto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0225","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1471-4159.1992.tb08460.x","article-title":"Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidosis","volume":"59","author":"Kobayashi","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005072-196901000-00003","article-title":"Chemical pathology of GM1-gangliosidosis (generalized gangliosidosis)","volume":"28","author":"Suzuki","year":"1969","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0235","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1471-4159.1994.62051852.x","article-title":"Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside","volume":"62","author":"Siegel","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0240","article-title":"Sphingolipids and neuronal degeneration in lysosomal storage disorders","author":"Grassi","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ymgme.2015.12.002","article-title":"Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel beta-galactosidase:RTB lectin fusion","volume":"117","author":"Condori","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.mt.6300004","article-title":"Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery","volume":"15","author":"Broekman","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007733","article-title":"Sustained Normalization of Neurological Disease after Intracranial Gene Therapy in a Feline Model","volume":"6","author":"McCurdy","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2016.10.001","article-title":"Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis","volume":"120","author":"Ou","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.11.002_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2017.12.300","article-title":"Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease","author":"Ou","year":"2018","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921830550X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921830550X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:22:09Z","timestamp":1761088929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921830550X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S109671921830550X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.11.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}